Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 50,000 shares at $31.40 ($1.6M) on 2023-06-16, disclosed to the SEC on 2023-06-20.
Seasonal sale ($1.6M) by President and CEO — this insider has traded DNLI in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |